Gene Therapy - Table of Contents alert Volume 22 Issue 10

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 22, Issue 10 (October 2015) In this issue Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement View most cited articles — which ones have you missed? Take a look at what your colleagues have been viewing across the Gene Therapy journal over the past two years. Click here to visit special webpage   Original Articles Top Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1–9 and lentiviral vectors S A Hoyng, F De Winter, S Gnavi, L van Egmond, C L Attwell, M R Tannemaat, J Verhaagen and M J A Malessy Gene Ther 2015 22: 767-780; advance online publication, May 4, 2015; 10.1038/gt.2015.47 Abstract | Full Text Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules A B Rodriguez-Peña, J Gomez-Rodriguez, R L Kortum, D C Palmer, Z Yu, G C Guittard, E A Wohlfert, P B Silver, J A Misplon, C L Sommers, L Feigenbaum, S L Epstein, R R Caspi, Y Belkaid, N P Restifo, L E Samelson and L Balagopalan Gene Ther 2015 22: 781-792; advance online publication, June 18, 2015; 10.1038/gt.2015.48 Abstract | Full Text Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo OPEN P-H Zhou, J-B Zheng, G-B Wei, X-L Wang, W Wang, N-Z Chen, J-H Yu, J-F Yao, H Wang, S-Y Lu and X-J Sun Gene Ther 2015 22: 793-801; advance online publication, May 25, 2015; 10.1038/gt.2015.49 Abstract | Full Text Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro J C Evans, J McCarthy, C Torres-Fuentes, J F Cryan, J Ogier, R Darcy, R W Watson and C M O’Driscoll Gene Ther 2015 22: 802-810; advance online publication, May 25, 2015; 10.1038/gt.2015.50 Abstract | Full Text Viral vector-based improvement of optic nerve regeneration: characterization of individual axons’ growth patterns and synaptogenesis in a visual target B J Yungher, X Luo, Y Salgueiro, M G Blackmore and K K Park Gene Ther 2015 22: 811-821; advance online publication, May 25, 2015; 10.1038/gt.2015.51 Abstract | Full Text CRISPR–Cas9-mediated gene knockout in primary human airway epithelial cells reveals a proinflammatory role for MUC18 H W Chu, C Rios, C Huang, A Wesolowska-Andersen, E G Burchard, B P O’Connor, T E Fingerlin, D Nichols, S D Reynolds and M A Seibold Gene Ther 2015 22: 822-829; advance online publication, July 2, 2015; 10.1038/gt.2015.53 Abstract | Full Text Gene transfer engineering for astrocyte-specific silencing in the CNS N Merienne, A Delzor, A Viret, N Dufour, M Rey, P Hantraye and N Déglon Gene Ther 2015 22: 830-839; advance online publication, June 5, 2015; 10.1038/gt.2015.54 Abstract | Full Text Short Communication Top Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors M Trepel, J Körbelin, E Spies, M B Heckmann, A Hunger, B Fehse, H A Katus, J A Kleinschmidt, O J Müller and S Michelfelder Gene Ther 2015 22: 840-847; advance online publication, June 2, 2015; 10.1038/gt.2015.52 Abstract | Full Text Corrigendum Top Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors M Trepel, J Körbelin, E Spies, M B Heckmann, A Hunger, B Fehse, H A Katus, J A Kleinschmidt, O J Müller and S Michelfelder Gene Ther 2015 22: 848; 10.1038/gt.2015.76 Full Text Advertisement Submit your work to The Pharmacogenomics Journal Covering multiple areas of medicine including cancer, cardiovascular, clinical immunology, precision & personalised medicine, The Pharmacogenomics Journal could be the place for your research. Reach an audience of over 77,000 with an Impact Factor of 4.229*. *(2014 Journal Citation Reports® - Thomson Reuters, 2015) Find out more: http://bit.ly/1W1vu5H   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.